Reporting of Cardiovascular Events in Clinical Trials Supporting FDA Approval of Contemporary Cancer Therapies
Janice M. Bonsu(The Ohio State University Wexner Medical Center), Daniel Addison(The University of Texas Southwestern Medical Center), Brandee Baker(The Ohio State University Wexner Medical Center), Hani Jneid(The University of Texas MD Anderson Cancer Center), Patrick Ruz(The Ohio State University Wexner Medical Center), Electra D. Paskett(Ohio University), Lai Wei(Tongji University), Eric D. Miller(The Ohio State University), Avirup Guha(The Ohio State University), Farrukh T. Awan(The University of Texas Southwestern Medical Center), Raquel E. Reinbolt(The Ohio State University), M. Wesley Milks(The Ohio State University Wexner Medical Center), Maryam B. Lustberg(Yale Cancer Center), Lawrence Charles(The Ohio State University Wexner Medical Center), Jonathan E. Brammer(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Vedat Yildiz(The Ohio State University), Rebecca R. Carter(The Ohio State University Wexner Medical Center)
Cited by 73
Related Papers
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
|Journal of the American College of Cardiology|2014|3.6k
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive Summary
|Circulation|2014|1.3k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k